- US-listed companies
- enVVeno Medical Corp
- Income statement
enVVeno Medical Corp (NVNO) Income statement
Market cap
$226.39M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 186,552 | 31,243 | - | - | - | - | - |
| Revenue growth (%) | - | - | - | - | - | - | |
| Gross profit | 186,552 | - | - | - | - | - | - |
| Gross margin (%) | - | - | - | - | - | - | |
| Research & development | 1 | 2 | 4 | 6 | 10 | 14 | 12 |
| Selling, general & administrative | 6 | 5 | 5 | 11 | 15 | 12 | 12 |
| Operating margin (%) | - | - | - | - | - | ||
| Operating income | -7,854,785 | -7,675,312 | -9,135,126 | -16,892,503 | -25 | -25 | -24 |
| Net income | -13,042,709 | -7,625,397 | -9,135,486 | -16,527,822 | -25 | -24 | -22 |
| Net income margin (%) | - | - | - | - | - | ||
| Earnings per share | - | - | - | - | -2.2 | -1.91 | -1.27 |
| Diluted EPS | - | - | - | - | -2.2 | -1.91 | -1.27 |